Advertisement

News Roundup: December 19 to December 23

Your weekly roundup of the latest news from Drug Topics®.

FDA Approves First-In-Class Twice-Yearly Treatment for HIV

Lenacapavir was approved with the FDA's Breakthrough Therapy Designation.

Read More

CBD May Help Mitigate Opioid Withdrawal Symptoms

In the midst of an opioid epidemic, CBD may help patients experiencing opioid withdrawal symptoms find relief.

Advertisement

Read More

Examining Rates of COVID-19 Rebound With Antiviral Therapies

Research tells a different story than recent news headlines.

Read more

Copay Caps for Insulin Lower Total Spending for Medicare Beneficiaries

The Medicare Part D Senior Savings Model—a CMS effort to test $35 copays for insulin—led to lowered total costs for beneficiaries.

Read more

How General Vaccine Hesitancy Is Impacting Teen COVID-19 Vaccination Rates

The COVID-19 vaccine rate for teenagers lags behind vaccination rates for adults. Does parental hesitancy for vaccines in general play a role?

Read more


Advertisement
Advertisement